{"id":37,"date":"2020-05-25T16:37:32","date_gmt":"2020-05-25T07:37:32","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/0_web\/?page_id=37"},"modified":"2025-04-09T10:21:03","modified_gmt":"2025-04-09T01:21:03","slug":"%e3%82%b7%e3%83%b3%e3%83%81-ct-mri%e9%83%a8%e9%96%80","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=37","title":{"rendered":"\u30b7\u30f3\u30c1\/CT\/MRI\u90e8\u9580"},"content":{"rendered":"
\n

1\uff0e\u90e8\u9580\u306e\u7d39\u4ecb<\/h4>\n

\u2460\u5fc3\u81d3\u6838\u533b\u5b66<\/h5>\n

\u5fc3\u81d3\u6838\u533b\u5b66\u691c\u67fb\u306f30<\/span>\u5e74\u4f59\u308a\u5229\u7528\u3055\u308c\u3066\u304d\u305f\uff0c\u6b74\u53f2\u306e\u3042\u308b\u975e\u4fb5\u8972\u6027\u753b\u50cf\u8a3a\u65ad\u6cd5\u3067\u3059\uff0e2007<\/span>\u5e74NEJM<\/span>\u306b\u767a\u8868\u3055\u308c\u305fCOURAGE Trial<\/span>\u3067\u306f\uff0c\u81f3\u9069\u5185\u79d1\u6cbb\u7642\u7fa4\u3068\u81f3\u9069\u5185\u79d1\u6cbb\u7642\u306bPCI<\/span>\u3092\u884c\u3063\u305f\u7fa4\u306e\uff17\u5e74\u9593\u306e\u4e88\u5f8c\uff08\u6b7b\u4ea1\u3068\u5fc3\u7b4b\u6897\u585e\u306e\u30a4\u30d9\u30f3\u30c8\u30d5\u30ea\u30fc\u7387\uff0c\u751f\u5b58\u7387\uff0c\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u304b\u3089\u306e\u30a4\u30d9\u30f3\u30c8\u30d5\u30ea\u30fc\u7387\uff0c\u5fc3\u7b4b\u6897\u585e\u306e\u30a4\u30d9\u30f3\u30c8\u30d5\u30ea\u30fc\u7387\uff09\u306b\u306f\u5dee\u306f\u306a\u304b\u3063\u305f\u4e8b\u304c\u8a3c\u660e\u3055\u308c\u307e\u3057\u305f\uff0e\u305d\u306e\u30b5\u30d6\u89e3\u6790(Circulation 2008)<\/span>\u3067\u306f\uff0c\u8ca0\u8377\u5fc3\u7b4b\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u3067\u4e2d\u7b49\u5ea6\u4ee5\u4e0a\u306e\u865a\u8840\u304c\u8a3c\u660e\u3055\u308c\uff0c\uff15\uff05\u4ee5\u4e0a\u306e\u865a\u8840\u304c\u6539\u5584\u3055\u308c\u305f\u75c7\u4f8b\u7fa4\u306b\u95a2\u3057\u3066\u306f\uff0c\u4e88\u5f8c\u304c\u6975\u3081\u3066\u826f\u597d\u3067\u3042\u3063\u305f\u3068\u5831\u544a\u3055\u308c\u3066\u3044\u307e\u3059\uff0e\u305d\u306e\u5f8c\u3082\u5fc3\u81d3\u6838\u533b\u5b66\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u84c4\u7a4d\u304c\u9032\u307f\uff0c\u5fc3\u7b4b\u865a\u8840\u306a\u3089\u3073\u306b\u5fc3\u7b4b\u30d0\u30a4\u30a2\u30d3\u30ea\u30c6\u30a3\uff08\u5fc3\u7b4b\u306e\u6d3b\u52d5\u6027\u304c\u7dad\u6301\u3055\u308c\u3066\u3044\u308b\u304b\u3069\u3046\u304b\u3068\u3044\u3046\u3053\u3068\uff09\u306e\u8a55\u4fa1\u304c\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u6cbb\u7642\u65b9\u91dd\u6c7a\u5b9a\u306b\u975e\u5e38\u306b\u91cd\u8981\u3067\u3042\u308b\u3053\u3068\u304c\u308f\u304b\u3063\u3066\u304d\u307e\u3057\u305f\uff0e<\/p>\n

\u5fc3\u7b4b\u8840\u6d41\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u306b\u306f99m<\/span><\/sup>Tc(<\/span>\u30c6\u30af\u30cd\u30b7\u30a6\u30e0)<\/span>\u88fd\u5264\u3067\u3042\u308b99m<\/span><\/sup>Tc-MIBI<\/span>\u306899m<\/span><\/sup>Tc-tetorofosmin<\/span>\u3068\u3001201<\/span><\/sup>Tl(<\/span>\u30bf\u30ea\u30a6\u30e0)<\/span>\u88fd\u5264\u304c\u3042\u308a\uff0c\u524d\u8005\u306f\u534a\u6e1b\u671f\u304c\u77ed\u304f\uff0c\u5927\u91cf\u6295\u4e0e\u304c\u53ef\u80fd\u306e\u305f\u3081\u9ad8\u753b\u8cea\u3067\u3042\u308a\uff0c\u5fc3\u6a5f\u80fd(<\/span>\u5de6\u5ba4\u306e\u53ce\u7e2e\u30fb\u62e1\u5f35\u80fd)<\/span>\u8a55\u4fa1\u3082\u53ef\u80fd\u3067\u3042\u308b\u3053\u3068\u304b\u3089\u5f53\u9662\u3092\u542b\u3081\u5168\u56fd\u7684\u306b\u983b\u7528\u3055\u308c\u3066\u304d\u3066\u3044\u307e\u3059\uff0e\u305d\u306e\u4ed6\u306b\u5f53\u9662\u3067\u306f\uff0c\u5fc3\u7b4b\u8102\u80aa\u9178\u4ee3\u8b1d\u306e\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u88fd\u5264\u3067\u3042\u308b123<\/span><\/sup>I-BMIPP<\/span>\uff08\u51a0\u6523\u7e2e\u3084\u305f\u3053\u3064\u307c\u578b\u5fc3\u7b4b\u75c7\u3067\u898b\u3089\u308c\u308b\u3088\u3046\u306a\u4ee3\u8b1d–<\/span>\u8840\u6d41\u30df\u30b9\u30de\u30c3\u30c1\u306e\u8a55\u4fa1\u7b49\u306b\u7528\u3044\u308b\uff09\u3084\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u88fd\u5264\u3067\u3042\u308b123<\/span><\/sup>I-MIBG<\/span>\uff08\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\u306b\u4ee3\u8868\u3055\u308c\u308b\u5fc3\u4e0d\u5168\u5fc3\u306e\u8a55\u4fa1\u306a\u3089\u3073\u306b\u4e0d\u6574\u8108\u306e\u8a55\u4fa1\u7b49\uff09\u306b\u3088\u308b\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3082\u884c\u3063\u3066\u3044\u307e\u3059\uff0e\u307e\u305fPET<\/span>\u3067\u306f\u5fc3\u7b4b\u7cd6\u4ee3\u8b1d\u8a55\u4fa1\u3084\u708e\u75c7\u306e\u8a55\u4fa1\u304c\u53ef\u80fd\u3067\u3042\u308a\uff0c18<\/span><\/sup>F-FDG-PET<\/span>\u306e\u64ae\u50cf\u3092\u884c\u306a\u3063\u3066\u3044\u307e\u3059\uff0e\u7cd6\u8ca0\u8377\u3092\u884c\u3046\u3068\u5fc3\u7b4b\u30d0\u30a4\u30a2\u30d3\u30ea\u30c6\u30a3\u306e\u8a55\u4fa1\u3092\uff0c\u7a7a\u8179\u6642\u306b\u64ae\u50cf\u3059\u308b\u3068\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306a\u3069\u5fc3\u81d3\u306e\u708e\u75c7\u306e\u8a55\u4fa1\u304c\u53ef\u80fd\u3068\u306a\u308a\u307e\u3059\uff0e<\/p>\n

\u8fd1\u5e74\u3067\u306f\u3055\u3089\u306b\u9032\u3093\u3060\u89e3\u6790\u65b9\u6cd5\u3068\u3057\u3066\u51a0\u52d5\u8108CT<\/span>\u3068SPECT<\/span>\u306efusion<\/span>\u753b\u50cf\u3092\u69cb\u7bc9\u3057\uff0c\u5b9f\u969b\u306e\u51a0\u52d5\u8108\u306e\u8840\u6d41\u652f\u914d\u306b\u5408\u308f\u305b\u305f\u8aad\u5f71\u3084\uff0c\u5fc3\u96fb\u56f3\u540c\u671f99m<\/span><\/sup>Tc-SPECT<\/span>\u3067\u306e\u4f4d\u76f8\u89e3\u6790\u306b\u3088\u308b\u5de6\u5ba4\u540c\u671f\u4e0d\u5168(dyssynchrony)<\/span>\u306e\u8a55\u4fa1\u3082\u884c\u3063\u3066\u3044\u307e\u3059\uff0e\u307e\u305f\uff0c\u4e2d\u6027\u8102\u80aa\u84c4\u7a4d\u5fc3\u7b4b\u8840\u7ba1\u75c7(TGCV)<\/span>\u3068\u8a00\u308f\u308c\u308b\u5e0c\u5c11\u75be\u60a3\u306e\u8a3a\u65ad\u306b\uff0c123<\/span><\/sup>I-BMIPP<\/span>\u306e\u6d17\u3044\u51fa\u3057\u7387\u306e\u8457\u660e\u306a\u4f4e\u4e0b\u3092\u304c\u8a8d\u3081\u3089\u308c\u308b\u3053\u3068\u304c\u8a3a\u65ad\u57fa\u6e96\u3068\u306a\u3063\u3066\u304a\u308a\uff0c\u539f\u56e0\u4e0d\u660e\u306e\u3073\u307e\u3093\u6027\u51a0\u52d5\u8108\u75be\u60a3\uff0c\u5de6\u5ba4\u6a5f\u80fd\u4e0d\u5168\u75c7\u4f8b\u306b\u5bfe\u3057\u3066\u691c\u67fb\u304c\u884c\u308f\u308c\u3066\u3044\u307e\u3059\uff0e\u5fc3\u81d3\u6838\u533b\u5b66\u5206\u91ce\u306f\u6b74\u53f2\u7684\u306b\u3082\u30a8\u30d3\u30c7\u30f3\u30b9\u304c\u8c4a\u5bcc\u306a\u9818\u57df\u3067\u3059\u304c\uff0c\u3055\u3089\u306b\u65e5\u3005\u9032\u6b69\u3057\u3066\u304a\u308a\uff0c\u305d\u306e\u9700\u8981\u306f\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\uff0e\u5f53\u9662\u3067\u306f\u5faa\u74b0\u5668\u5185\u79d1\u533b\u5e2b\uff0c\u6838\u533b\u5b66\u79d1\u533b\u5e2b\uff0c\u653e\u5c04\u7dda\u6280\u5e2b\uff0c\u307e\u305f\u5fc3\u81d3\u8840\u7ba1\u30bb\u30f3\u30bf\u30fc\u653e\u5c04\u7dda\u79d1\u533b\u5e2b\u306a\u3069\u306b\u3088\u308a\uff0c\u8cea\u306e\u9ad8\u3044\u5fc3\u81d3\u6838\u533b\u5b66\u691c\u67fb\u3092\u76ee\u6307\u3057\u3066\u65e5\u3005\u306e\u696d\u52d9\u3092\u884c\u3063\u3066\u304a\u308a\u307e\u3059\uff0e<\/p>\n

\u2461\u51a0\u52d5\u8108CT<\/h5>\n

\u51a0\u52d5\u8108CT\u306f\u4e3b\u306b\u975e\u4fb5\u8972\u7684\u306b\u51a0\u52d5\u8108\u3092\u8a55\u4fa1\u3059\u308b\u3053\u3068\u306b\u7528\u3044\u3089\u308c\u3066\u3044\u307e\u3059\u3002CT\u306e\u6280\u8853\u7684\u306a\u767a\u9054\u306b\u3088\u308a64\u5217\u306e\u691c\u51fa\u5668\u3092\u7528\u3044\u3066\u5fc3\u96fb\u56f3\u540c\u671f\u64ae\u5f71\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f2004\u5e74\u304b\u3089\u3001\u3053\u3053\u6570\u5e74\u3067\u6025\u901f\u306b\u666e\u53ca\u3057\u3066\u304d\u3066\u304a\u308a\u307e\u3059\u3002\u5f53\u9662\u3067\u306f320\u5217CT\u3092\u64ae\u5f71\u306b\u7528\u3044\u3066\u304a\u308a\u307e\u3059\u3002\u591a\u5217\u5316\u306e\u30e1\u30ea\u30c3\u30c8\u3068\u3057\u3066\u30a2\u30fc\u30c1\u30d5\u30a1\u30af\u30c8\u304c\u51fa\u306b\u304f\u3044\u3001\u88ab\u66dd\u91cf\u3092\u5f93\u6765\u3088\u308a\u3082\u6291\u3048\u3089\u308c\u308b\u3001\u4e0d\u6574\u8108\u306b\u5f37\u3044\u3001\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u3001\u753b\u8cea\u306e\u5411\u4e0a\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u308b\u3068\u601d\u308f\u308c\u307e\u3059\u3002
\n\u5f97\u3089\u308c\u308b\u7d50\u679c\u306e\u7279\u5fb4\u3068\u3057\u3066\u3001\u51a0\u52d5\u8108\u306e\u72ed\u7a84\u306e\u307f\u306a\u3089\u305a\u3001\u30d7\u30e9\u30fc\u30af\u6027\u72b6\u306e\u8a55\u4fa1\u3082\u53ef\u80fd\u3067\u3042\u308a\u3001\u4e0d\u5b89\u5b9a\u30d7\u30e9\u30fc\u30af\u3092\u898b\u3064\u3051\u51fa\u3059\u3053\u3068\u306b\u3088\u308a\u3001\u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u65e9\u671f\u767a\u898b\u30fb\u65e9\u671f\u6cbb\u7642\u306b\u7d50\u3073\u3064\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u6162\u6027\u9589\u585e\u6027\u75c5\u5909\u306b\u304a\u3044\u3066\u3082\u3001\u30ab\u30c6\u30fc\u30c6\u30eb\u6cbb\u7642\u306e\u524d\u306b\u884c\u3046\u3053\u3068\u3067\u3001\u9589\u585e\u90e8\u306e\u786c\u3055\u3084\u9577\u3055\u3001\u8d70\u884c\u306a\u3069\u3001\u6cbb\u7642\u306b\u6709\u7528\u306a\u60c5\u5831\u3092\u5f97\u308b\u3053\u3068\u304c\u53ef\u80fd\u3067\u3059\u3002\u307e\u305f\u51a0\u52d5\u8108\u30ab\u30eb\u30b7\u30a6\u30e0\u30b9\u30b3\u30a2(\u77f3\u7070\u5316\u306e\u5ea6\u5408\u3044)\u306f\u51a0\u75be\u60a3\u767a\u75c7\u306e\u72ec\u7acb\u3057\u305f\u4e88\u5f8c\u56e0\u5b50\u3068\u3057\u3066\u77e5\u3089\u308c\u3066\u304a\u308a\u3001\u5c06\u6765\u306e\u5fc3\u8840\u7ba1\u30a4\u30d9\u30f3\u30c8\u30ea\u30b9\u30af\u306e\u63a8\u5b9a\u306b\u3082\u5f79\u7acb\u3061\u307e\u3059\u3002<\/p>\n

\u2462\u5fc3\u81d3MRI<\/h5>\n

\u5fc3\u81d3MRI\u306f\u88ab\u66dd\u3092\u305b\u305a\u3001\u975e\u4fb5\u8972\u7684\u3067\u3042\u308a\u3001\u3053\u3053\u6570\u5e74\u3067\u6280\u8853\u7684\u306a\u9032\u6b69\u304c\u8457\u3057\u3044\u30e2\u30c0\u30ea\u30c6\u30a3\u3067\u3059\u3002\u5fc3\u81d3\u306e\u52d5\u304d\u3092\u6b7b\u89d2\u306a\u304f\u89b3\u5bdf\u3067\u304d\u308b\u307b\u304b\u3001\u5fc3\u7b4b\u306e\u6d6e\u816b\u30fb\u708e\u75c7\u306e\u8a55\u4fa1\u3084\u3001\u9020\u5f71\u5264\u3092\u4f7f\u7528\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u5c40\u6240\u306e\u5fc3\u7b4b\u969c\u5bb3\u3084\u7dda\u7dad\u5316\u3082\u53ef\u8996\u5316\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u305d\u308c\u306b\u3088\u308a\u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u75c5\u5909\u306e\u691c\u51fa\u3084\u3001\u51a0\u52d5\u8108\u75c5\u5909\u3092\u4f34\u308f\u306a\u3044\u5fc3\u6a5f\u80fd\u4f4e\u4e0b\u4f8b\u306b\u304a\u3044\u3066\u3001\u305d\u306e\u539f\u56e0\u306e\u63a8\u5b9a\u306a\u3069\u306b\u7528\u3044\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u6700\u8fd1\u3067\u306fT1\u30de\u30c3\u30d4\u30f3\u30b0\u3068\u3044\u3046\u624b\u6cd5\u3067\u5fc3\u7b4b\u5168\u4f53\u306e\u7570\u5e38\u3092\u691c\u51fa\u3057\u305f\u308a\u3001\u5c02\u7528\u306e\u30ef\u30fc\u30af\u30b9\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u7528\u3044\u3066\u53f3\u5ba4\u306e\u6a5f\u80fd\u3092\u8a55\u4fa1\u3057\u305f\u308a\u3068\u3001\u5fc3\u81d3\u3092\u3088\u308a\u5305\u62ec\u7684\u306b\u8a55\u4fa1\u3059\u308b\u3053\u3068\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u307e\u3059\u3002<\/p>\n<\/section>\n

\n

2\uff0e\u6240\u5c5e\u30e1\u30f3\u30d0\u30fc\uff08\u95a2\u9023\u75c5\u9662\u3082\u542b\u3080\uff09<\/h4>\n

\u77f3\u6a4b\u6d0b\u5e73\uff0c\u6a0b\u53e3\u5fb9\u4e5f\uff08\u6838\u533b\u5b66\u79d1\uff09\uff0c\u4e45\u91ce\u8cb4\u5f18\uff0c\u5c0f\u5c71\u6075\u5b50\uff08\u7fa4\u99ac\u770c\u7acb\u5fc3\u81d3\u8840\u7ba1\u30bb\u30f3\u30bf\u30fc\u653e\u5c04\u7dda\u79d1\uff09\uff0c\u5927\u5c71\u5584\u662d\uff08\u5148\u7aef\u533b\u7642\u958b\u767a\u30bb\u30f3\u30bf\u30fc\uff09\uff0c\u7b20\u9593\u5468\uff08\u6ecb\u8cc0\u533b\u79d1\u5927\u5b66\u81e8\u5e8a\u7814\u7a76\u958b\u767a\u30bb\u30f3\u30bf\u30fc\uff09<\/p>\n<\/section>\n

\n

3\uff0e\u8a3a\u7642\u5b9f\u7e3e<\/h4>\n

2016\u5e74\u306e\u5fc3\u7b4b\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3(PET\u9664\u304f)\u306f\u5168\u4f53\u3067138 \u4ef6\u3067\u3057\u305f\u3002\u3046\u3061\u3001\u8ca0\u8377\u5fc3\u7b4b\u8840\u6d41\u30b7\u30f3\u30c1\u306f97\u4ef6\u3067\u3001\u305d\u306e\u5185\u8a33\u306f\u904b\u52d5\u8ca0\u8377 32\u4ef6\u3001\u85ac\u5264\u8ca0\u8377 65\u4ef6\u3067\u3057\u305f\u3002\u307e\u305f\u5fc3\u7b4b\u8102\u80aa\u9178\u4ee3\u8b1d\u306e\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u88fd\u5264\u3067\u3042\u308b123I-BMIPP\u30b7\u30f3\u30c1\u304c 35\u4ef6\u3001\u307e\u305f\u5fc3\u81d3\u4ea4\u611f\u795e\u7d4c\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u88fd\u5264\u3067\u3042\u308b123I-MIBG\u306f 5\u4ef6\u3067\u3057\u305f\u3002
\n\u540c\u69d8\u306b\u30012016\u5e74\u306eCardiac CT\u306f\u3001202\u4ef6\u3001\u5fc3\u81d3MRI\u306f61\u4ef6\u3067\u3057\u305f\u3002<\/p>\n<\/section>\n

\n

4\uff0e\u4e3b\u50ac\u3057\u3066\u3044\u308b\u7814\u7a76\u4f1a<\/h4>\n

\u5171\u50ac\u3068\u3044\u3046\u304b\u305f\u3061\u3067\u7fa4\u99ac\u770c\u6838\u533b\u5b66\u7814\u7a76\u4f1a\u3084\u81e8\u5e8a\u753b\u50cf\u8a3a\u65ad\u61c7\u8a71\u4f1a\u304c\u3042\u308a\u3001\u524d\u8005\u306f\u5e74\uff12\u56de\u3001\u5f8c\u8005\u306f\u5e74\uff11\u56de\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u7fa4\u99ac\u770c\u306e\u6838\u533b\u5b66\u306e\u63a8\u9032\u306b\u5f79\u7acb\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<\/section>\n

\n

5\uff0e\u8ad6\u6587\u30fb\u5b66\u4f1a\u767a\u8868\u5b9f\u7e3e<\/h4>\n

\u4e3b\u8981\u306a\u8ad6\u6587<\/strong>
\n1\uff09Kasama S, Toyama T, Kurabayashi M.\u3000 Can combined assessment of baroreflex sensitivity and iodine-123 metaiodobenzylguanidine imaging be used for risk stratification of patients with type 2 diabetes mellitus?\u3000 Circ J. 2012;77(1):49-50.<\/p>\n

2\uff09Yagi H, Toyama T, Kasama S, Koitabashi N, Arai M, Yokoyama T, Adachi H, Naito S, Hoshizaki H, Oshima S, and Kurabayashi M. Relation Between Connective Tissue Growth Factor and Cardiac Sympathetic Nerve Activity In Heart Failure of DCM Patients. International Heart Journal. 2012;53:282-236.<\/p>\n

3\uff09Nakahara T, Takahashi-Tateno R, Hasegawa A, Kimura T, Tsushima Y, Murakami M, Kurabayashi M.\u3000Doppler echocardiography may provide a potentially life-saving screening of anomalous origin of coronary artery in young athletes.\u3000Int J Cardiol. 2012 Apr 5;156(1):104-5.<\/p>\n

4\uff09Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M.\u3000Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure.\u3000Int J Cardiol. 2012 Jan 13<\/p>\n

5\uff09Nakahara T, Jinzaki M, Fukuda N, Takahashi Y, Ishihara T, Takada A, Suzuki K, Manita M, Imanari T, Kanesawa N, Kuribayashi S, Kurabayashi M.\u3000Estimation of the left ventricular diastolic function with cardiac MDCT: correlation of the slope of the time-enhancement-curve with the mitral annulus diastolic velocity.\u3000\u3000Eur J Radiol. 2012 Feb;81(2):234-8. doi<\/p>\n

6\uff09Toyama T, Hoshizaki H, Kasama S, Yamashita E, Kawaguchi R, Adachi H,
\nOshima S, Hasegawa A, Kurabayashi M. Low-dose and long-term G-CSF
\ntreatment can improve severe myocardial ischemia in patients with
\nsevere coronary artery disease. J Nucl Cardiol. 2011;18:463-471.<\/p>\n

7\uff09Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M.\u3000Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction. Heart. 2011 Jan;97\uff081\uff09:20-6.<\/p>\n

8\uff09Nakahara T, Takahashi R, Tomita T, Kurabayashi M.\u3000Collaboration between cardiac computed tomography and echocardiography in complex anomalies.\u3000Eur Heart J. 2010 Jan;31(1):58<\/p>\n

9\uff09Nakahara T, Manita M, Kurabayashi M.\u3000A thrombus stuck in the ostium of the coronary artery.\u3000Eur Heart J. 2009 Jan;30(1):24.<\/p>\n

10\uff09Ueda T, Toyama T, Seki R, Hoshizaki H, Oshima S, Taniguchi K, Endo K, Kurabayashi M. Prediction of functional outcome in stunned myocardium after myocardial infarction using BMIPP and tetrofosmin imaging. J Int Med Res. 2009;37:367-377.<\/p>\n

11\uff09 Seki R, Seki H, Toyama T, Koyama K, Endo K, Kurabayashi M. Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: Comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography. J Cardiol. 2009;53:265-271.<\/p>\n

12\uff09 Kasama S, Furuya M, Toyama T, Ichikawa S, Kurabayashi M. Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction. Eur Heart J. 2008;22:36-38.<\/p>\n

13\uff09Toyama T, Hoshizaki H, Yoshimura Y, Kasama S, Isobe N, Adachi H,
\nOshima S, Taniguchi K. Combined therapy with carvedilol and amiodarone
\nis more effective in improving cardiac symptoms, function, and
\nsympathetic nerve activity in patients with dilated cardiomyopathy:
\ncomparison with carvedilol therapy alone. J Nucl Cardiol. 2008;15:57-64.<\/p>\n

14\uff09 Hatori T, Toyama T, Kasama S, Suguta M, Nakano A, Hasegawa A, Endo K, Kurabayashi M. 123I-MIBG imaging can be used to evaluate microvascular disturbance caused by embolization by microdebris after rotational atherectomy. Ann Nucl Med. 2007;21:137-144<\/p>\n

15\uff09 Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M. Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J. 2006;70:703-709.<\/p>\n

16\uff09 Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2005;45:661-667.<\/p>\n

17\uff09Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction. Eur J Nucl Med Mol Imaging. 2005;32:322-328.<\/p>\n

18\uff09 Seki H, Toyama T, Higuchi K, Kasama S, Ueda T, Seki R, Hatori T, Endo K, Kurabayashi M. Prediction of functional improvement of ischemic myocardium with 123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: a study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J. 2005;69:311-319.<\/p>\n

19\uff09Okumura W, Iwasaki T, Toyama T, Iso T, Arai M, Oriuchi N, Endo K, Yokoyama T, Suzuki T, Kurabayashi M. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med. 2004;45:1989-1998.<\/p>\n

20\uff09Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2003;19:574-581<\/p>\n

21\uff09Toyama T, Hoshizaki H, Seki R, Isobe N, Adachi H, Naito S, Oshima S, Taniguchi K. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy. J Nucl Med. 2003; 44:1604-11.<\/p>\n

22\uff09Sato H, Iwasaki T, Toyama T, Kaneko Y, Inoue T, Endo K, Nagai R. Prediction of functional recovery after revascularization in coronary artery disease using 18F-FDG and 123I-BMIPP SPECT. Chest. 2000;117:65-72.<\/p>\n

23\uff09Toyama T, Aihara Y, Iwasaki T, Hasegawa A, Suzuki T, Nagai R, Endo K, Hoshizaki H, Oshima S and Taniguchi K. Cardiac Sympathetic Activity Estimated by I-123 Metaiodobenzylguanidine Myocardial Imaging in Patients with Dilated Cardiomyopathy After \u03b2-Blocker or ACE Inhibitor Therapy. The Journal of Nuclear Medicine. 1999;40: 217-223.
\n\u7b49\u3005<\/p>\n

\n\n\n\n\n\n
\"14-1\"
\nAquiilion ONE ViSION\u3092\u306f\u3058\u3081\u3068\u3057\u305f\u6a5f\u5668\u3068CT\u753b\u50cf\u3001CT-SPECT fusion\u753b\u50cf\uff08CT\/SPECT scanner including \u201cAquillion ONE ViSION\u201d,\u3000Cardiac CT image and CT-SPECT fusion image\uff09<\/td>\n		\"14-2\"
\n\u56fd\u969b\u5b66\u4f1a\u3067\u767a\u8868\u4e2d\u306e\u5916\u5c71\u5148\u751f\u3002\uff08Dr Toyama in EANM\uff09<\/td>\n<\/tr>\n
\"14-3\"
\n\u5fc3\u81d3\u75c5\u5b66\u4f1a\u3067\u306e\u512a\u79c0\u8cde\u6388\u8cde\u5f0f\u304a\u3088\u3073ESC\u62db\u8058\u8b1b\u6f14\u4e2d\u306e\u7b20\u9593\u5148\u751f\u3002\uff08Dr Kasama received YIA award in JCC and performed invited presentation in ESC.\uff09<\/td>\n		\"14-4\"
\n\u79c1\u3084\u4f50\u85e4\u5148\u751f\u3068\u3044\u3063\u305f\u82e5\u624b\u3082\u9811\u5f35\u3063\u3066\u3044\u307e\u3059\u3002\uff08Dr Nakahara and Dr Sato in Congresses\uff09<\/td>\n<\/tr>\n
\"14-5\"
\n\u5b66\u4f1a\u6642\u306e\u98df\u4e8b\u4f1a\u3002\uff08\u6ce8\uff1a\u697d\u3057\u304f\u306a\u3063\u3066\u3001\u4ed6\u5927\u5b66\u306e\u5148\u751f\u3082\u5199\u3063\u3066\u3044\u307e\u3059\uff09\u3002\uff08A party during a Scientific Session.\uff09<\/td>\n		<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

1\uff0e\u90e8\u9580\u306e\u7d39\u4ecb \u2460\u5fc3\u81d3\u6838\u533b\u5b66 \u5fc3\u81d3\u6838\u533b\u5b66\u691c\u67fb\u306f30\u5e74\u4f59\u308a\u5229\u7528\u3055\u308c\u3066\u304d\u305f\uff0c\u6b74\u53f2\u306e\u3042\u308b\u975e\u4fb5\u8972\u6027\u753b\u50cf\u8a3a\u65ad\u6cd5\u3067\u3059\uff0e2007\u5e74NEJM\u306b\u767a\u8868\u3055\u308c\u305fCOURAGE Trial\u3067\u306f\uff0c\u81f3\u9069\u5185\u79d1\u6cbb\u7642\u7fa4\u3068\u81f3\u9069\u5185\u79d1\u6cbb\u7642\u306bPCI\u3092\u884c\u3063\u305f\u7fa4\u306e\uff17\u5e74 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":11,"menu_order":19,"comment_status":"closed","ping_status":"closed","template":"tpl_column2.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-37","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/37","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=37"}],"version-history":[{"count":8,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/37\/revisions"}],"predecessor-version":[{"id":933,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/37\/revisions\/933"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/11"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=37"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}